FMP
XOMA Corporation
XOMA
NASDAQ
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
19.44 USD
-0.37 (-1.9%)
Balance Sheet
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Total Cash
514.05M
753.17M
1.15B
472.53M
1.43B
1.59B
2.01B
2.55B
3.22B
4.08B
Total Cash %
63.44
62.64
82.28
28.65
69.9
61.38
61.38
61.38
61.38
Receivables
370.45M
454.37M
-
-
799.13M
634.39M
803.29M
1.02B
1.29B
1.63B
Receivables %
45.72
37.79
-
-
39.12
24.52
24.52
24.52
24.52
Inventories
-594.84M
-710.43M
-2.3B
-
-
-1.2B
-1.52B
-1.93B
-2.44B
-3.09B
Inventories %
-73.41
-59.08
-164.58
-
-
-46.5
-46.5
-46.5
-46.5
Payable
243.34M
285.98M
347.84M
580.33M
529.06M
723.2M
915.75M
1.16B
1.47B
1.86B
Payable %
30.03
23.78
24.89
35.19
25.9
27.96
27.96
27.96
27.96
Cap Ex
-6.69M
-2.76M
-10.73M
-14.03M
-4.03M
-14.86M
-18.81M
-23.82M
-30.16M
-38.19M
Cap Ex %
-0.83
-0.23
-0.77
-0.85
-0.2
-0.57
-0.57
-0.57
-0.57
